Showing results (91-100 of 359) with videos related to

Sort By:
Pageof 36
Journal of Cellular and Molecular Medicine|May 12, 2009
VEGFR2+PDGFRbeta+ circulating precursor cells participate in capillary restoration after hyperoxia acute lung injury (HALI)Rosemary Jones, Diane E Capen, Margaretha Jacobson, et al.
Stem Cells (Dayton, Ohio)|February 20, 2014
Stress hematopoiesis is regulated by the Krüppel-like transcription factor ZBP-89Xiangen Li, Rachael D Romain, Dongsu Park, et al.
Genome Biology|June 21, 2018
dropEst: pipeline for accurate estimation of molecular counts in droplet-based single-cell RNA-seq experimentsViktor Petukhov, Jimin Guo, Ninib Baryawno, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasmsShangqin Guo, Haitao Bai, Cynthia M Megyola, et al.
Stem Cell Reports|July 13, 2022
Recent advances in "sickle and niche" research - Tribute to Dr. Paul S FrenetteLidiane S Torres, Noboru Asada, Mitchell J Weiss, et al.
Blood|October 7, 2024
How I treat blastic plasmacytoid dendritic cell neoplasmMohamed A Kharfan-Dabaja, Andrew A Lane, Naveen Pemmaraju
The American Journal of Surgical Pathology|December 6, 2005
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasmHenry Y Dong, David T Scadden, Laurence de Leval, et al.
Blood|April 19, 2003
Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cellsSebastian Stier, Tao Cheng, Randolf Forkert, et al.
European Journal of Immunology|March 19, 2013
Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patientsMarta Ruiz-Riol, Beatriz Mothe, Rajesh T Gandhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study TeamAriela Noy, David T Scadden, Jeannette Lee, et al.
Pageof 36